1h Free Analyst Time
The autoinjectors market is forecasted to grow byUSD 303.65 billion during 2023-2028, accelerating at a CAGR of 36.72% during the forecast period. The report on the autoinjectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies and need for immediate care, growing popularity of injectable therapies, and rise in commercial approvals of new products.
The autoinjectors market is segmented as below:
By Application
- Anaphylaxis
- Multiple sclerosis
- Rheumatoid arthritis
- Diabetes
By End-user
- Hospitals and clinics
- Self-administration
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the autoinjectors market covers the following areas:
- Autoinjectors market sizing
- Autoinjectors market forecast
- Autoinjectors market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global autoinjectors market: AbbVie Inc., Amgen Inc., Bayer AG, Becton Dickinson and Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Halozyme Therapeutics Inc., Johnson and Johnson Services Inc., Johnson Medtech LLC, medmix Ltd., Merck KGaA, Owen Mumford Ltd., Pfizer Inc., RAVIMED Sp. zoo, Recipharm AB, SHL Medical AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic alliances between companies."
According to the report, one of the major drivers for this market is the increasing prevalence of allergies and need for immediate care.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Bayer AG
- Becton Dickinson and Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Halozyme Therapeutics Inc.
- Johnson and Johnson Services Inc.
- Johnson Medtech LLC
- medmix Ltd.
- Merck KGaA
- Owen Mumford Ltd.
- Pfizer Inc.
- RAVIMED Sp. zoo
- Recipharm AB
- SHL Medical AG
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Ypsomed Holding AG
